Dolomite and Clearbridge BioMedics develop revolutionary instrument for cancer detection
White Paper Nov 22, 2011
Dolomite is delighted to announce its collaboration with Clearbridge BioMedics in the development of a novel instrument capable of detecting and isolating Circulating Tumour Cells (CTCs) from small quantities of whole, unprocessed blood.
The innovative ClearCell™ System can isolate, enumerate and most importantly retrieve wholly intact and viable CTCs from patient whole blood. Benefiting a broad range of application areas including molecule analysis, cancer diagnostics and cancer treatment decisions, this revolutionary instrument also paves the way for personalised cancer medication for patients.
Speaking of this success, Andrew Lovatt, the CEO of Dolomite, says, “We are excited to be working with an innovative company like Clearbridge BioMedics. The collaboration is an excellent example of how Dolomite is able to help start-up companies productize science. By combining the cutting edge scientific research of Clearbridge BioMedics and National University of Singapore with the proven track record in product development of Dolomite, both companies have leveraged their expertise to gain early traction in the
This white paper can be viewed by following the attached link.
Related White Papers
Big Data Lipidomics for Lipid Biomarker Identification and Drug DiscoveryWhite Paper
Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.
Immunofluorescence Visualization of Fibroblast or Cancer Cells in RAFT™ 3D Cell CulturesWhite Paper
Applying standard microscopy techniques on 3D cell cultures can be challenging. This white paper demonstrates how RAFT™ 3D Cell Cultures can be visualized with subcellular resolution under a standard fluorescence microscope.READ MORE
QC Explained 1.0 - Quality Control for Point of Care TestingWhite Paper
By following the guidelines outlined in this paper in addition to ISO 15189 and ISO 22870:2006 you can be assured that the management and overall results of your POCT devices will be of a higher and more reliable quality.READ MORE
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018